Hiroyoshi Nakanishi
Hiroyoshi Nakanishi publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Oncology, on topics such as Gastric Cancer Management and Outcomes, Esophageal Cancer Research and Treatment and Esophageal and GI Pathology.
- World rank
- #2,235,590 of 7,710,434 ranked researchers
- Rank in Japan
- #42,856 of 383,136
- Works
- 60
- Citations
- 686
- Citations per work
- 11.4
What does Hiroyoshi Nakanishi research?
Hiroyoshi Nakanishi's work is mostly in Medicine (85%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5184.6%
- Medicine5184.6%
- Everything else915.4%
- 1Surgery38% of their works
- 2Pulmonary and Respiratory Medicine25% of their works
- 3Oncology7% of their works
- 4Gastroenterology6% of their works
- 5Otorhinolaryngology6% of their works
- 6Pathology and Forensic Medicine4% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Esophageal Cancer Research and Treatment
- Esophageal and GI Pathology
- Helicobacter pylori-related gastroenterology studies
- Head and Neck Cancer Studies
- Colorectal Cancer Screening and Detection
- Metastasis and carcinoma case studies
- Gastrointestinal Tumor Research and Treatment
Which keywords describe Hiroyoshi Nakanishi's research?
The keywords of their largest research topics: Endoscopic Resection, Gastric Cancer, Chemotherapy, Lymph Node Dissection, Molecular Characterization, Esophageal Carcinoma, Preoperative Chemoradiotherapy and Prevention.
- Sunitinib
- Screening
- Lung Tumors
- Oropharyngeal Cancer
- Inflammation
- Esophageal Perforation
- Prevention
- Esophageal Carcinoma
- Lymph Node Dissection
- Gastric Cancer
- Endoscopic Resection
- Chemotherapy
- Molecular Characterization
- Preoperative Chemoradiotherapy
- Endoscopic Stenting
- Helicobacter pylori
- Human Papillomavirus
- Colorectal Cancer
- Metastatic Carcinomas
- Imatinib Mesylate
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Endoscopic Resection522 topics
- Gastric Cancer392 topics
- Chemotherapy362 topics
- Lymph Node Dissection281 topic
- Molecular Characterization281 topic
- Esophageal Carcinoma241 topic
- Preoperative Chemoradiotherapy241 topic
- Prevention172 topics
- Endoscopic Stenting121 topic
- Esophageal Perforation121 topic
- Helicobacter pylori111 topic
- Inflammation111 topic
- Human Papillomavirus81 topic
- Oropharyngeal Cancer81 topic
- Colorectal Cancer61 topic
- Lung Tumors61 topic
- Metastatic Carcinomas61 topic
- Screening61 topic
- Imatinib Mesylate51 topic
- Sunitinib51 topic
Where does Hiroyoshi Nakanishi work?
Hiroyoshi Nakanishi's main affiliation in the publication record is Ishikawa Prefectural Central Hospital, Japan.
How many publications and citations does Hiroyoshi Nakanishi have?
OpenAlex counts 60 works and 686 citations for Hiroyoshi Nakanishi, an h-index of 14, ranking #2,235,590 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hiroyoshi Nakanishi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.